Contralateral breast cancer risk in BRCA1/2-positive families needs to be adjusted for phenocopy rates particularly in second-degree untested relatives

Lignende værker

• Can multiple SNP testing in BRCA2 and BRCA1 female carriers be used to improve risk prediction models in conjunction with clinical assessment?
  af: Prosperi, Mattia CF, et al.
  Udgivet: (2014)
• Are BRCA1- and BRCA2-related breast cancers associated with increased mortality?
  af: Gareth Evans, D, et al.
  Udgivet: (2004)
• Risks of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers
  af: Ahmed, M, et al.
  Udgivet: (2010)
• BRCA phenocopies or ascertainment bias?
  af: Goldgar, David, et al.
  Udgivet: (2007)
• Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
  af: Dominguez-Valentin, Mev, et al.
  Udgivet: (2018)